CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 2,134	$ 1,586
General and administrative	1,468	1,054
Total operating expenses	3,602	2,640
Operating loss	(3,602)	(2,640)
Total other expense, net	0	(2)
Net loss	$ (3,602)	$ (2,642)
Net loss per common share:
Basic	$ (3.15)	$ (2.34)
Diluted	$ (3.15)	$ (2.34)
Weighted average number of common shares outstanding
Basic	1,142,213	1,130,344
Diluted	1,142,213	1,130,344